Cytogenetic manifestation of chromosome 11 duplication/amplification in acute myeloid leukemia

Cancer Genetics and Cytogenetics

Volumn 199, Issue 2, 2010, Pages 121-127

  Šárová, Iveta ^a   Březinová, Jana ^a   Zemanová, Zuzana ^b   Izáková, Silvia ^a   Lizcová, Libuše ^b   Malinová, Eva ^b   Berková, Adéla ^b   Čermák, Jaroslav ^a   Maaloufová, Jacqueline ^a   Nováková, Ludmila ^a   Michalová, Kyra ^a,b  

^a INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

MIXED LINEAGE LEUKEMIA PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; AMPLICON; ARTICLE; CHROMOSOME 11; CHROMOSOME 11Q; CHROMOSOME ANALYSIS; CHROMOSOME DUPLICATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PARTIAL TRISOMY; PRIORITY JOURNAL;

ADULT; AGED; CHROMOSOMES, HUMAN, PAIR 11; FEMALE; GENE AMPLIFICATION; GENE DUPLICATION; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; TRISOMY;

EID: 77952776651     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2010.02.012     Document Type: Article

References (28)

1. Schwab M. Oncogene amplification in solid tumors. Semin Cancer Biol 1999, 9:319-325.
2. Avet-Loiseau H., Gordon C., Li J.Y., Daviet A., Mellerin M.P., Talmant P., et al. Amplification of the 11q23 in acute myeloid leukemia. Genes Chromosomes Cancer 1999, 26:166-170.
3. Cuthbert G., Thompson K., McCullough S., Watmore A., Dickinson H., Telford N., et al. MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study. Leukemia 2000, 14:1885-1891.
4. Michaux L., Wlodarska I., Stul M., Dierlamm J., Mugneret F., Herens C., et al. MLL amplification in myeloid leukemias: a study of 14 cases with multiple copies of 11q23. Genes Chromosomes Cancer 2000, 29:40-47.
5. Streubel B., Valent P., Jager U., Edelhauser M., Wandt H., Wagner T., et al. Amplification of the MLL gene on double minutes, a homogenously staining region, and ring chromosomes in five patients with acute myeloid leukemia or myelodysplastic syndrome. Genes Chromosome Cancer 2000, 27:380-386.
6. Andersen M.K., Christiansen D.H., Kirchhoff M., Pedersen-Bjergaard J. Duplication or amplification of chromosome band 11q23, including the unrearranged MLL gene, is a recurrent abnormality in therapy-related MDS and AML, and is closely related to mutation of the TP53 gene and to previous therapy with alkylating agents. Genes Chromosomes Cancer 2001, 31:33-41.
7. Tyybäkinoja A., Saarinen-Pihkala U., Elonen E., Knuutila S. Amplified, lost, and fused genes in 11q23-25 amplicon in acute myeloid leukemia, an array-CGH study. Genes Chromosomes Cancer 2006, 45:257-264.
8. Felix C.A., Meginigal M.D., Chervinsky D.S., Leonard D.G.B., Tsuchida N., Kakati S., et al. Association of germline p53 mutation with MLL segmental jumping translocation in treatment-related leukemia. Blood 1998, 12:4451-4456.
9. Tanaka K., Kamada N. Segmental jumping translocation in leukemia and lymphoma with a highly complex karyotype. Leuk Lymphoma 1998, 29:563-575.
10. Arnaud B., Douet-Guilbert N., Morel F., Le Bris M.J., Herry A., Banzakour S., et al. Screening by fluorescence in situ hybridization for MLL status at diagnosis in 239 unselected patients with acute myeloblastic leukemia. Cancer Genet Cytogenet 2005, 161:110-115.
11. Tanaka K., Takechi M., Nishimura S., Oguma N., Kamada N. Amplification of c- MYC oncogene and point mutation of N- RAS oncogene point mutation in acute myelocytic leukemias with double minute chromosomes. Leukemia 1993, 7:469-471.
12. Poppe B., Vandesompele J., Schoch C., Lindvall C., Mrozek K., Bloomfield C.D., et al. Expression analyses identify MLL as a prominent target of 11q23 amplification and support an etiologic role for MLL gain of function in myeloid malignancies. Blood 2004, 103:229-235.
13. Zatkova A., Merk S., Wendehack M., Bilban M., Muzik E.M., Muradyan A., et al. AML/MDS with 11q/ MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes. Genes Chromosomes Cancer 2009, 48:510-520.
14. Zatkova A., Schoch C., Speleman F., Poppe B., Mannhalter C., Fonatsch C., et al. GAB2 is a novel target of 11q amplification in AML/MDS. Genes Chromosomes Cancer 2006, 45:798-807.
15. Hess J.L., Yu B.D., Li B., Hanson R., Korsmeyer S.J. Defects in yolk sac hematopoiesis in Mll-null embryos. Blood 1997, 90:1799-1806.
16. Papenhausen P.R., Griffin S., Tepperberg J. Oncogene amplification in transforming myelodysplasia. Exp Mol Pathol 2005, 79:168-175.
17. Maitta R.W., Cannizzaro L.A., Ramesh K.H. Association of MLL amplification with poor outcome in acute myeloid leukemia. Cancer Genet Cytogenet 2009, 192:40-43.
18. ISCN: an international system for human cytogenetic nomenclature 2009, S. Karger, Basel. L.G. Shaffer, M.L. Slovak, L.J. Cambel (Eds.).
19. Rayeroux K.C., Campbell L.J. Gene amplification in myeloid leukemias elucidated by fluorescence in situ hybridization. Cancer Genet Cytogenet 2009, 193:44-53.
20. Bae S.Y., Kim J.S., Han E.A., Lim C.S., Ryeu B.J., Lee K.N., et al. Concurrent MYC and MLL amplification on dmin and hsr in acute myeloid leukemia. Leuk Lymphoma 2008, 49:1823-1825.
21. Dolan M., McGlennen R.C., Hirsch B. MLL amplification in myeloid malignancies: clinical, molecular, and cytogenetic findings. Cancer Genet Cytogenet 2002, 134:93-101.
22. Pajuelo-Gámez J.C., Cervera J., García-Casado Z., Mena-Durán A.V., Valencia A., Barragán E., et al. MLL amplification in acute myeloid leukemia. Cancer Genet Cytogenet 2007, 174:127-131.
23. Reddy K.S., Parsons L., Mak L., Dighe P., Saphner T., Crow M.K., et al. Segmental amplification of 11q23 region identified by fluorescence in situ hybridization in four patients with myeloid disorders: a review. Cancer Genet Cytogenet 2001, 126:139-146.
24. Van Limbergen H., Poppe B., Janssens A., De Bock R., De Paepe A., Noens L., et al. Molecular cytogenetic analysis of 10;11 rearrangements in acute myeloid leukemia. Leukemia 2002, 16:344-351.
25. Stasevich I., Utskevich R., Kustanovich A., Litvinko N., Savitskaya T., Chernyavskaya S., et al. Translocation (10;11) (p12;q23) in childhood acute myeloid leukemia: incidence and complex mechanism. Cancer Genet Cytogenet 2006, 169:114-120.
26. Klaus M., Schnittger S., Haferlach T., Dreyling M., Hiddemann W., Schoch C. Cytogenetics, fluorescence in situ hybridization, and reverse transcriptase polymerase chain reaction are necessary to clarify the various mechanisms leading to an MLL-AF10 fusion in acute myelocytic leukemia with 10;11 rearrangement. Cancer Genet Cytogenet 2003, 144:36-43.
27. Jarosova M., Takacova S., Holzerova M., Priwitzerova M., Divoka M., Lakoma I., et al. Cryptic MLL-AF10 fusion cause by insertion of duplicated 5' part of MLL into 10p12 in acute leukemia: a case report. Cancer Genet Cytogenet 2005, 162:179-182.
28. Zatkova A., Ullmann R., Rouillard J.M., Lamb B.J., Kuick R., Hanash S.M., et al. Distinct sequences on 11q13.5 and 11q23-24 are frequently coamplified with MLL in complexly organized 11q amplicons in AML/MDS patients. Genes Chromosomes Cancer 2004, 39:263-276.